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Churg-Strauss syndrome (CSS) is a multisystem granulo-
matous vasculitis that is characterized by peripheral 
eosinophilia and the infiltration of eosinophils into systemic 
organs. The skin lesions of CSS consist mainly of palpable 
purpura and nodules. Wells' syndrome (WS) is a rare 
inflammatory dermatosis that is associated with recurrent 
granulomatous dermatitis and eosinophilia. Since these two 
diseases are rare, any overlap between them is very unusual. 
Herein, we report a patient with CSS, who initially 
presented a skin eruption of erythematous urticarial-pla-
ques, vesicles, and blisters. Upon biopsy, the histology of 
these plaques indicated eosinophilic infiltration and “fla-
me figures“ within the dermis, which was consistent with 
a diagnosis of WS. Although the association between WS 
and CSS that was observed in our patient may be purely 
coincidental, it could also suggest a common pathogene-
tic background of these two distinct diseases, as both 
share several many common features. (Ann Dermatol 
23(4) 497∼500, 2011)
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INTRODUCTION
Wells’ syndrome (WS), which was later named eosino-
philic cellulitis, is a rare inflammatory dermatosis that was 
first described as a recurrent granulomatous dermatitis 
with concomitant eosinophilia by Wells in 19711. 
Although the pathophysiology of WS remains unclear, it is 
now believed to represent a specific hypersensitivity 
reaction to various exogenous and endogenous stimuli, 
such as insect bites, infections, drug eruption or un-
derlying internal disorders2. Conversely, Churg-Strauss 
syndrome (CSS) is a multisystem granulomatous vasculitis 
that primarily affects patients with asthma. Classically, CSS 
is characterized by interstitial eosinophilic infiltrates, 
extravascular granulomas, which occur in a variety of 
organs, and peripheral eosinophilia. To date, only four 
cases of overlap between these two diseases have been 
described2-5. Here, we report a 57-year-old female with 
known CSS, who later developed a bullous skin eruption 
that was clinically and histologically consistent with WS.
CASE REPORT
A 57-year-old woman came to our clinic with multiple 
erythematous tense vesicles and blisters with secondary 
yellowish crusts on both forearms, as well as multiple 
pruritic, erythematous, and annular plaques on her trunk 
(Fig. 1). She reported a history of asthma, bilateral maxillary 
sinusitis, vasculitis, and peripheral sensory-motor poly-
neuropathy in the lower extremities, all of which fulfilled 
the American College of Rheumatology criteria for CSS6. A 
skin biopsy from a blister on her arm revealed the 
presence of multiple intraepidermal vesicles and sub-
epidermal blisters, with perivenular and interstitial 
infiltrations of lymphocytes and eosinophils in the super-
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Fig. 1. (A) Both forearms contained
multiple tense bullae based on 
erythematous patch with secon-
dary yellowish crusts. (B) Multiple 
erythematous edematous annular 
plaques on the trunk, with some 
central darkening.
Fig. 2. (A) Multiple intraepidermal 
vesicles and subepidermal blisters 
with underlying perivenular and 
interstitial inflammatory cell infil-
trations in the superficial and deep
dermis (H&E, ×40). (B) Perivenular 
and interstitial infiltration of lym-
phocytes and eosinophils forming 
"flame figures" (H&E, ×400). 
ficial and deep dermis. Notably, these infiltrations also 
formed characteristic “flame figure“ aggregates in the 
dermis, which was consistent with a diagnosis of WS (Fig. 
2). Subsequent direct immunofluorescence microscopy 
did not show any immunoglobin or complement deposits 
in the lesional skin. An additional laboratory analysis 
revealed a white blood cell count of 5.71×109/L with 
peripheral eosinophilia (24.3%), an erythrocyte sedimentation 
rate of 112 mm/h, a C-reactive protein level of 4.22 mg/dl, 
and a negative anti-neutrophil cytoplasmic antibody 
(anti-MPO, p-ANCA). In the chest X-ray and chest 
computed tomography (CT), a diffusely increased opacity 
was noted in both lower lobes, whereas the echocardio-
graphy and abdomen CT did not indicate any associated 
pathologies. The patient was subsequently treated with 
oral predinosolone (1 mg/kg per day), which resolved the 
bullous skin lesions, as well as reduced the pain and 
pruritus for several days. The oral prednisolone was 
subsequently tapered over three weeks, and, 1 week after 
discontinuing all previous medications, she redeveloped 
the same rash. Consequently, treatment with oral predi-
nosolone was restarted (1 mg/kg per day), and after a 
1-month tapering, the skin lesions improved significantly. 
She is currently under regular surveillance. 
DISCUSSION
WS is a rare, often recurrent, inflammatory disorder that is 
characterized by indurated urticarial erythematous pla-
ques, similar to those seen in cellulitis. Pathologically, the 
characteristic feature of WS is “flame figures”, which are 
histiocyte and giant cell aggregates surrounding collagen 
bundles that are coated with eosinophilic granules. These 
flame figures represent histological cutaneous reaction 
patterns specific to eosinophil-mediated dermatoses, most 
commonly WS, bullous pemphigoid, herpes gestationis, 
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prurigo, eczema, or dermatophyte infections1. WS can 
present either solitary or multiple cutaneous lesions, 
which typically resolve spontaneously after several weeks 
with some residual atrophy and hyperpigmentation7. The 
other clinical manifestations of WS are quite diverse 
morphologically and range from cellulitis-like manife-
stations to less common bullous or vesicular lesions8. 
Affected patients often develop recurrences months to 
years after the initial presentation9, and peripheral eosino-
philia is present in about 50% of all cases2. 
CSS is characterized by the constellation of severe asthma, 
fever, hypereosinophilia, and symptoms of vascular im-
pairment in various organ systems10. Although the patho-
genesis of CSS remains unknown, it is now classified as a 
form of ANCA-associated small-vessel vasculitis (even 
though ANCA is present in less 50% of patients)11, and 
most current data suggests that CSS is induced by some 
allergenic or environmental trigger in pre-sensitized 
patients with asthma. Since CSS is primarily a clinical 
diagnosis, the American College of Rheumatology has 
established six separate criteria to facilitate the identifi-
cation of affected individuals: (1) asthma (defined as a 
history of wheezing or diffuse, high-pitched wheezes 
upon expiration), (2) eosinophilia of ＞10% in differential 
white blood cell counts, (3) mononeuropathy (including 
multiplex) or polyneuropathy, (4) migratory or transient 
pulmonary opacities detected radiographically, (5) the 
presence of paranasal sinus abnormalities and (6) 
histologic evidence of perivascular eosinophil accumu-
lation. In individuals with documented vasculitis, the 
presence of four or more of these criteria yields a 
diagnostic sensitivity and specificity for CSS of 85% and 
99.7%, respectively. In the case of our patient, all criteria 
were fulfilled. Notably, the involvement of skin in CSS is 
not rare, occurring in roughly 40∼70% of all patients, 
and classically presents as erythematous maculopapules, 
haemorrhagic lesions, or cutaneous and subcutaneous 
nodules2, while bullous lesions are substantially less 
common. Histologically, CSS is characterized by a triad of 
systemic vasculitis, eosoniphilic tissue infiltration, and 
extravascular granulomas. “Flame figures”, however, have 
never been described in CSS, except in case reports of 
CSS-related WS. Thus, in our case, the bullous lesions 
were considered to be a WS-related symptom. Bullae are 
frequently present in WS5, and in most cases, they 
develop on top of urticarial erythematous plaques and cap 
a small area of the plataeu.
Hypothetically, CSS could induce WS via the pathogenic 
affects of the associated eosinophils that infiltrate through 
the skin. It is assumed that the eosinophilic inflammatory 
processes that target the skin, nerves, and blood vessels 
result from the underlying CSS pathophysiology. 
Accordingly, when diverted into the skin, which is 
possibly due to an additional unknown trigger, these same 
processes may produce “flame figures” histologically, and 
the bullous form of WS clinically4. Interestingly, Churg 
and Strauss suggested in their initial report that WS may 
be related to CSS, due to the similarity of the histo-
pathologic changes associated with both conditions10. In 
regards to the treatment of CSS with WS, we found that 
prednisolone at a dose of 1 mg/kg was an effective 
therapeutic regimen5.
Notably, in all reported cases of CSS/WS overlap, CSS 
always preceded WS, suggesting that WS should be 
considered in the differential diagnosis of patients with 
CSS whose clinical presentation includes erythematous 
urticarial plaques. Although the association between these 
two conditions may be purely coincidental, it could also 
represent a common pathogenetic background, since both 
WS and CSS share many main features, including 
peripheral and/or tissue eosinophilia and widespread 
eosinophilic infiltration into multiple organs.
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